These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6086978)

  • 1. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
    Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
    Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S
    Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
    Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
    Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum alpha-1-fetoprotein and serum lactic dehydrogenase isoenzymes in liver tumours (author's transl)].
    Polterauer P; Rauhs R; Puxkandl H
    Wien Klin Wochenschr; 1981 Apr; 93(7):227-30. PubMed ID: 6167076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic transaminase activity in alocholic liver disease.
    Matloff DS; Selinger MJ; Kaplan MM
    Gastroenterology; 1980 Jun; 78(6):1389-92. PubMed ID: 7372058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of human serum and liver tissue immunoreactive gamma-glutamyl transpeptidase in patients with various liver diseases].
    Yamada M
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):44-55. PubMed ID: 2896151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of glutamic acid dehydrogenase].
    Rettenbacher-Däubner H; Rieder H; Sburny I
    Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GOT and GPT: interpretation of the test results].
    Suzuki H; Endo Y
    Nihon Rinsho; 1969 Mar; ():1027-34. PubMed ID: 5408750
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
    Asaka M; Nagase K; Miyazaki T; Alpert E
    Gastroenterology; 1983 Jan; 84(1):155-60. PubMed ID: 6183164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor].
    Takahashi T; Takami H; Abe O; Ootake T; Kano S
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1480-6. PubMed ID: 6204598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer.
    Theodoropoulos G; Economopoulos P; Mitakos S; Angelopoulos Ba
    Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
    Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
    Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.